
FLOW TRADERS Q122 TRADING UPDATE
FLOW TRADERS Q122 TRADING UPDATE
Amsterdam, the Netherlands - Flow Traders N.V. (Euronext: FLOW) announces its unaudited Q122 trading update.
Highlights
- Market ETP Value Traded increased by 41% quarter-on-quarter and by 62% vs Q121
- Flow Traders ETP Value Traded increased by 27% quarter-on-quarter and by 26% vs Q121
- Flow Traders NTI increased to €148.0m in Q122 reflecting a more active market environment and strong trading performance. This compares to NTI of €80.3m in Q421 and €142.2m in Q121
- Normalized operating expenses of €75.8m incurred in Q122. Employee expenses reflect increased variable remuneration due to an improved operating result, impact of strategic headcount growth and the implementation of targeted base compensation increases. Other expenses include non-recurring advisory costs relating to the firm’s recent corporate strategy and group legal structure review and the implementation of a corporate venture capital unit
- 624 FTEs as at 31 March 2022 compared to 613 FTEs as at 31 December 2021
- Normalized EBITDA in Q122 reached €72.2m representing a margin of 49% compared to Normalized EBITDA in Q421 of €32.6m with a margin of 41%
- Q122 Normalized net profit amounted to €54.0m with Normalized basic EPS of €1.24
- Regulatory Own Funds Requirement (OFR) as at 31 March 2022 was €365m, resulting in excess capital of €175m as at 31 March 2022. Trading capital stood at €607m at the end of the first quarter
Normalized Financial Overview
€million | Q122 | Q421 | Change | Q122 | Q121 | Change |
Net trading income | 148.0 | 80.3 | 84% | 148.0 | 142.2 | 4% |
EMEA (Europe) | 108.2 | 59.8 | 81% | 108.2 | 81.4 | 33% |
Americas | 21.5 | 8.1 | 165% | 21.5 | 38.8 | (45%) |
APAC | 18.3 | 12.4 | 48% | 18.3 | 22.1 | (17%) |
Net trading income | 148.0 | 80.3 | 84% | 148.0 | 142.2 | 4% |
Normalized employee expenses1 | 52.8 | 29.3 | 80% | 52.8 | 51.3 | 3% |
Technology expenses | 13.8 | 13.2 | 4% | 13.8 | 11.9 | 16% |
Other expenses | 9.2 | 4.6 | 98% | 9.2 | 3.4 | 168% |
One-off expenses | - | 0.6 | - | - | 0.7 | - |
Normalized operating expenses | 75.8 | 47.7 | 59% | 75.8 | 67.3 | 13% |
Normalized EBITDA1 | 72.2 | 32.6 | 122% | 72.2 | 74.9 | (4%) |
Depreciation / amortisation | 3.8 | 3.9 | 3.8 | 3.7 | ||
Write off of (in) tangible assets | 0.2 | - | 0.2 | - | ||
Results of equity-accounted investments | 0.1 | (0.5) | 0.1 | - | ||
Normalized profit before tax | 68.2 | 29.3 | 133% | 68.2 | 71.2 | (4%) |
Tax | 14.2 | 7.5 | 14.2 | 13.2 | ||
Normalized net profit | 54.0 | 21.7 | 148% | 54.0 | 58.0 | (7%) |
Normalized basic EPS2 (€) | 1.24 | 0.50 | 1.24 | 1.31 | ||
Normalized EBITDA margin | 49% | 41% | 49% | 53% |
Value Traded Overview
€billion | Q122 | Q421 | Change | Q122 | Q121 | Change |
Flow Traders ETP Value Traded | 521.9 | 410.2 | 27% | 521.9 | 414.4 | 26% |
EMEA (Europe) | 238.2 | 181.5 | 31% | 238.2 | 199.4 | 19% |
Americas | 255.2 | 202.3 | 26% | 255.2 | 189.6 | 35% |
APAC ex China | 28.5 | 26.4 | 8% | 28.5 | 25.5 | 12% |
Flow Traders’ non-ETP Value Traded | 1,434 | 1,231 | 16% | 1,434 | 915 | 57% |
Market ETP Value Traded4 | 15,085 | 10,666 | 41% | 15,084 | 9,313 | 62% |
EMEA (Europe) | 767 | 532 | 44% | 767 | 590 | 30% |
Americas | 13,305 | 9,103 | 46% | 13,305 | 7,780 | 71% |
APAC | 1,013 | 1,032 | (2%) | 1,012 | 944 | 7% |
APAC ex China | 392 | 344 | 14% | 392 | 415 | (5%) |
Regional Highlights
EMEA:
- Standout trading performance across the region as Flow Traders maintained its position as the leading liquidity provider in ETPs, both on- and off-exchange - #1 position in fixed income, equity and commodity ETFs
- Further increases in Flow Traders’ market share in European single bond corporate credit across all the major RfQ platforms. This again highlights the continued traction of this business with counterparties
- Continued to support new crypto ETP listings in EMEA as well furthering the development of the broader digital asset ecosystem through participation, amongst other strategic investments, in BloXroute’s Series B funding round. BloXroute is the first and fastest blockchain distribution network
AMERICAS:
- Improved trading performance quarter-on-quarter, particularly in equity-related ETPs. Pro-actively repositioning certain trading strategies
- Further momentum in ETF Lead Market Maker activities- acted as Lead Market Maker in all seven debut high yield bond ETFs from new issuer BondBloxx
- Continued strategic focus on the fixed income business with increased volumes becoming evident on the major platforms including TradeWeb, MarketAxess, Bloomberg, ICE and MTS. Additional progress made in converting existing counterparties to transact in corporate credit
APAC:
- Strong trading performance in equity ETPs throughout the region
- Awarded Best ETF Market Maker by the Tokyo Stock Exchange and received the Top Market Maker - ETP Coverage award from the HKEX for Flow Traders' contribution to the ETF market in 2021. Flow Traders is currently a market maker in more than 200 ETPs on HKEX
- Expansion of Flow Traders’ global ETP trading footprint by becoming an official market maker on ASX and CBOE Australia in 55 tickers
Corporate Venture Capital Unit
- During 2021, Flow Traders designed and implemented a strategic ecosystem approach to accelerate the execution of its strategy and as well as capturing more of the overall value chain. This is a natural evolution given Flow Traders’ core capabilities as well as position within the financial markets ecosystem. The emphasis is on three key themes of platforms, data, and connectivity across the three strategic focus areas of equities, fixed income and digital assets
- Recent strategic activities made in line with these key themes include ErisX, MEMX, Shape Q, LedgerEdge, D2X, Pyth and BloXroute
- Significant work has been undertaken during the first quarter to formalize this strategic ecosystem approach into a dedicated corporate venture capital unit as the pace of investments continues to accelerate. The set-up of this unit is expected to be finalized by the end of the second quarter
Outlook
- To maintain Flow Traders’ status as an employer of choice and to remain competitive in the global employment market, it has been necessary to shift the total compensation mix of certain employee groups towards a greater fixed component. Accordingly, targeted base compensation increases have been implemented. These actions will ensure Flow Traders continues to attract the talent necessary to execute its strategic growth agenda
- The first quarter did see certain one-off strategy related costs being incurred, which are expected to deliver meaningful benefits going forward. In addition, COVID business continuity plan-related expenses were reclassified into operational expenses from the start of 2022. Nonetheless, Flow Traders continues to be focused on cost discipline particularly with reference to the maximum growth in fixed operating expenses of c. 15% for this year
Management Board Comments
Dennis Dijkstra, CEO, stated:
“The successes in Q1 once again confirmed the numerous strengths of our business.This includes our pricing and hedging excellence, a robust risk management framework and a truly global trading footprint. Astronger operational focus has been required so far in 2022 but this has not been to the detriment of progressing and driving forward our strategic growth agenda across our three key growth areas of equities, fixed incomeand digital assets.We continue to quote more products as well as support new introductions as the trading footprint continues to grow. Once again, we confirmed our ability to deploy into new markets by becoming an official market maker in Australia on the ASX and CBOE.
“Lastly, while this has been a successful quarter for Flow Traders, we are mindful that this has been an extremely challenging and distressing time for those affected by the conflict in Ukraine. Accordingly, we have made an initial donation of €500,000 to the Red Cross, UNHCR and several local initiatives nominated by colleagues and partners. We are also proud of the individual efforts from colleagueswho directly raised more than €40,000 through various activities and conducted a successful donation drive in the Amsterdam office. This continues our longstanding tradition of charitable giving.”
Folkert Joling, Chief Trading Officer, added:
“We saw a strong trading performance across the board with all desks and regions responding to a more active and volatile market environment.In particular, ETP flowsand volumes were focused in the European time zoneduring the quarter. We continued to expand and deepen our ETP trading footprint during the quarter as evidenced by our new market making activities in Australia and expanded Lead Market Maker activities in the US. Encouragingly, our market share in corporate credit single bond market making continues to increase both in Europe and in the US as the buyside engages further with our proposition. From a trading and operational standpoint, we were successfully able to navigate the various market issues that arose upon the start of the Ukraine conflict.”
Mike Kuehnel, Chief Financial Officer, added:
“We have made substantial progress in the review of our strategic roadmap with tangible ideas now ready for the team to action. We look forward to sharing these outputs at a capital markets day to be held in June. In parallel, we completed an investment in BloXroute as we further intensify our strategic ecosystem approach to drive change and innovation in global financial markets. Our increased pace of strategic investments has created a desire to formalise these activities within a dedicated corporate venture capital unitthat will help us to accelerate our ecosystem strategy even further. From a cost perspective, we have commenced the process of systematically adjusting the base compensation for certain targeted employee groups. There were also one-off expenses incurred this quarter relating to the recentcorporate strategy and group legal structure review. Notwithstanding these cost dynamics, the operational leverage within the business was still very much evident with significantly improved margins quarter on quarter, indicating that our operational leverage and underlying cost efficiency remain key priorities.”
Preliminary Financial Calendar
29 April 2022 AGM
3 May 2022 FY21 final dividend proposed ex-dividend date
4 May 2002 FY21 final dividend proposed record date
6 May 2022 FY21 final dividend proposed payment date
TBD June 2022 Capital markets day
30 June 2022 Start silent period ahead of H122 results
22 July 2022 Release H122 results (inc. analyst conference call)
16 August 2022 Proposed FY22 interim dividend ex-dividend date
17 August 2022 Proposed FY22 interim dividend record date
19 August 2022 Proposed FY22 interim dividend payment date
30 September 2022 Start silent period ahead of Q322 trading update
27 October 2022 Release Q322 trading update (no analyst conference call)
Contact Details
Flow Traders N.V.
Investors
Jonathan Berger
Phone: +31 20 7996799
Email: investor.relations@flowtraders.com
Media
Laura Peijs
Phone: +31 20 7996799
Email: press@flowtraders.com
About Flow Traders
Flow Traders is a leading global financial technology-enabled liquidity provider in financial products, historically specialized in Exchange Traded Products (ETPs), now expanding into other asset classes. Flow Traders ensures the provision of liquidity to support the uninterrupted functioning of financial markets. This allows investors to continue to buy or sell ETPs or other financial instruments under all market circumstances. We continuously grow our organization, ensuring that our trading desks in Europe, the Americas and Asia can provide liquidity across all major exchanges, globally, 24 hours a day. Founded in 2004, we continue to cultivate the entrepreneurial, innovative and team-oriented culture that has been with us since the beginning. Please visit www.flowtraders.com for more information.
IFRS Financial Overview
€million | Q122 | Q421 | Change | Q122 | Q121 | Change |
Net trading income | 148.0 | 80.3 | 84% | 148.0 | 142.2 | 4% |
EMEA (Europe) | 108.2 | 59.8 | 81% | 108.2 | 81.4 | 33% |
Americas | 21.5 | 8.1 | 165% | 21.5 | 38.8 | (45%) |
APAC | 18.3 | 12.4 | 48% | 18.3 | 22.1 | (17%) |
Net trading income | 148.0 | 80.3 | 84% | 148.0 | 142.2 | 4% |
Employee expenses1 | 54.9 | 37.0 | 49% | 54.9 | 47.0 | 17% |
Technology expenses | 13.8 | 13.2 | 4% | 13.8 | 11.9 | 16% |
Other expenses | 9.2 | 4.6 | 98% | 9.2 | 3.4 | 168% |
One-off expenses | - | 0.6 | - | - | 0.7 | - |
Total operating expenses | 77.9 | 55.4 | 41% | 77.9 | 63.0 | 24% |
EBITDA | 70.1 | 24.9 | 182% | 70.1 | 79.3 | (12%) |
Depreciation / amortisation | 3.8 | 3.9 | 3.8 | 3.7 | ||
Write off of (in) tangible assets | 0.2 | - | 0.2 | - | ||
Results of equity-accounted investments | 0.1 | (0.5) | 0.1 | - | ||
Profit before tax | 66.1 | 21.6 | 207% | 66.1 | 75.5 | (13%) |
Tax | 13.7 | 5.5 | 13.7 | 14.0 | ||
Net profit | 52.3 | 16.0 | 227% | 52.3 | 61.6 | (15%) |
Basic EPS2 (€) | 1.20 | 0.37 | 1.20 | 1.39 | ||
Fully diluted EPS3 (€) | 1.17 | 0.35 | 1.17 | 1.35 | ||
EBITDA margin | 47% | 31% | 47% | 56% |
Normalized to IFRS reconciliation
- Normalized EBITDA and margin are based on the standard 35% profit share of operating result across the various financial periods without any IFRS 2 adjustments for share-based payments
- Tax based on estimated expected effective tax rate for the relevant financial period: Q122 - 20.8%; Q421 - 25.7%; Q121 - 18.5%
- A reconciliation of Normalized to IFRS is presented below:
€million | Q122 | Q421 | Q121 |
Normalized EBITDA | 72.2 | 32.6 | 74.9 |
Prior year share plans | 7.9 | 8.6 | 4.5 |
Current year share plan deferral | (5.8) | (0.9) | (8.9) |
IFRS EBITDA | 70.1 | 24.9 | 79.3 |
€million | Q122 | Q421 | Q121 |
Normalized net profit | 54.0 | 21.7 | 58.0 |
EBITDA adjustments | 2.1 | 7.7 | (4.3) |
Tax difference | (0.4) | (2.0) | 0.8 |
IFRSnet profit | 52.3 | 16.0 | 61.6 |
Notes
- Fixed employee expenses: Q122 - €16.1m; Q421 - €13.5m; Q121 - €13.0m
- Weighted average shares outstanding: Q122 - 43,514,470; Q421 - 43,177,846; Q121 - 44,348,083. 43,683,405 shares outstanding as at 31 March 2022
- Determined by adjusting the basic EPS for the effects of all dilutive share-based payments to employees
- Source - Flow Traders analysis
Important Legal Information
This press release is prepared by Flow Traders N.V. and is for information purposes only. It is not a recommendation to engage in investment activities and you must not rely on the content of this document when making any investment decisions. The information in this document does not constitute legal, tax, or investment advice and is not to be regarded as investor marketing or marketing of any security or financial instrument, or as an offer to buy or sell, or as a solicitation of any offer to buy or sell, securities or financial instruments.
The information and materials contained in this press release are provided ‘as is’ and Flow Traders N.V. or any of its affiliates (“Flow Traders”) do not warrant the accuracy, adequacy or completeness of the information and materials and expressly disclaim liability for any errors or omissions. This press release is not intended to be, and shall not constitute in any way a binding or legal agreement, or impose any legal obligation on Flow Traders. All intellectual property rights, including trademarks, are those of their respective owners. All rights reserved. All proprietary rights and interest in or connected with this publication shall vest in Flow Traders. No part of it may be redistributed or reproduced without the prior written permission of Flow Traders.
This press release may include forward-looking statements, which are based on Flow Traders’ current expectations and projections about future events, and are not guarantees of future performance. Forward looking statements are statements that are not historical facts, including statements about our beliefs and expectations. Words such as “may”, “will”, “would”, “should”, “expect”, “intend”, “estimate”, “anticipate”, “project”, “believe”, “could”, “hope”, “seek”, “plan”, “foresee”, “aim”, “objective”, “potential”, “goal” “strategy”, “target”, “continue” and similar expressions or their negatives are used to identify these forward-looking statements. By their nature, forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors because they relate to events and depend on circumstances that will occur in the future whether or not outside the control of Flow Traders. Such factors may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. Accordingly, no undue reliance should be placed on any forward-looking statements. Forward-looking statements speak only as at the date at which they are made. Flow Traders expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statements contained in this press release to reflect any change in its expectations or any change in events, conditions or circumstances on which such statements are based unless required to do so by applicable law.
Financial objectives are internal objectives of Flow Traders to measure its operational performance and should not be read as indicating that Flow Traders is targeting such metrics for any particular fiscal year. Flow Traders’ ability to achieve these financial objectives is inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond Flow Traders’ control, and upon assumptions with respect to future business decisions that are subject to change. As a result, Flow Traders’ actual results may vary from these financial objectives, and those variations may be material.
Efficiencies are net, before tax and on a run-rate basis, i.e. taking into account the full-year impact of any measure to be undertaken before the end of the period mentioned. The expected operating efficiencies and cost savings were prepared on the basis of a number of assumptions, projections and estimates, many of which depend on factors that are beyond Flow Traders’ control. These assumptions, projections and estimates are inherently subject to significant uncertainties and actual results may differ, perhaps materially, from those projected. Flow Traders cannot provide any assurance that these assumptions are correct and that these projections and estimates will reflect Flow Traders’ actual results of operations.
By accepting this document you agree to the terms set out above. If you do not agree with the terms set out above please notify legal.amsterdam@nl.flowtraders.com immediately and delete or destroy this document.
Market Abuse Regulation
This press release contains information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
XPENG Oslo Experience Store Now Open With XPENG G3i and XPENG P5 Available for Local Test Drives19.5.2022 11:00:00 CEST | Press release
XPENG opens its first Brand Experience Store in the Bjørvika area of downtown Oslo on May 19, 2022.The launch of the fully electric XPENG P5 and XPENG G3i makes Norway the first European country to boast the full range of XPENG EVs. Local test drives are now available to customers.XPENG, in June this year, will be participating in the 35th International Electric Vehicle Symposium (EVS35) 2022, the world’s largest international EV event live from Oslo. OSLO, Norway, May 19, 2022 (GLOBE NEWSWIRE) -- XPENG, a leading electric vehicle manufacturer, is taking the next step in its European expansion by opening its first Norwegian Brand Experience Store in the Bjørvika area of Oslo on May 19. This coincides with the official launch of the brand's two latest models, XPENG G3i and XPENG P5. Establishing a Local Presence XPENG is one of the early adopters of a disruptive retail model in the European market, combining direct, in-store sales with wider agency collaboration. In the Oslo Brand Exper
IBFD launches the 2021 Yearbook on Taxpayers’ Rights19.5.2022 10:00:00 CEST | Press release
Today, IBFD launches the 2021 Yearbook on the Protection of Taxpayers’ Rights (OPTR). The book is a compilation of up-to-date information on the effective protection of taxpayers’ rights. AMSTERDAM, May 19, 2022 (GLOBE NEWSWIRE) -- Prof. Dr Pasquale Pistone and Prof. Dr Philip Baker, Directors of IBFD’s OPTR, will present the Yearbook at the 7th International Conference on Taxpayer Rights, hosted by the Center for Taxpayer Rights, explaining some of the main events and trends that arose last year in the protection of taxpayers’ rights around the world. Click here to watch the video. The OPTR reports on the protection of taxpayers’ fundamental rights around the world. The precise and technical information of the OPTR contains reference to taxpayer bills, conventions and statutes, including their judicial and administrative interpretation, which explore how states apply this protection in practice. The OPTR serves as a unique legal basis for developing further research on the legal remed
Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics19.5.2022 10:00:00 CEST | Press release
Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range Rijswijk, The Netherlands, May 19, 2022 (GLOBE NEWSWIRE) -- Summary Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial resistanceThe company is the first to publicly announce that Its entire supply chain of oral antibiotics – including its own and supplier manufacturing sites - is fully compliant with the stringent Predicted No Effect Concentration (PNEC) discharge targets set by the AMR Industry AllianceThis achievement demonstrates Centrient Pharmaceuticals’ commitment and leadership in the responsible production of antibiotics. Centrient Pharmaceuticals announces 100% compliance with the stringent Predicted No Effect Concentration (PNEC) discharge targets set by the AMR Industry Alliance for clean manufacturing of its full oral
Share Buyback Transaction Details May 12 – May 18, 202219.5.2022 10:00:00 CEST | Press release
Share Buyback Transaction Details May 12 – May 18, 2022 May 19, 2022 - Wolters Kluwer today reports that it has repurchased 118,000 of its own ordinary shares in the period from May 12, 2022, up to and including May 18, 2022, for €11.0 million and at an average share price of €92.92. These repurchases are part of the share buyback program announced on February 23, 2022, under which we intend to repurchase shares for up to €600 million during 2022. The cumulative amounts repurchased to date under this program are as follows: Share Buyback 2022 PeriodCumulative shares repurchased in period Total consideration (€ million)Average share price (€) 2022 to date 2,573,464 238.4 92.64 For the period starting May 5, 2022, up to and including August 1, 2022, we have engaged a third party to execute €140 million of buybacks on our behalf, within the limits of relevant laws and regulations (in particular Regulation (EU) 596/2014) and the company’s Articles of Association. Repurchased shares are add
Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert in Europe and the United Arab Emirates (UAE)19.5.2022 09:01:00 CEST | Press release
Dante Labs is a Global Leader in Genomics and Precision MedicineMainz is Exclusively Focused on Developing Next Generation Diagnostics for the Early Detection of Cancer BERKELEY, Calif. and MAINZ, Germany and NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer and Dante Labs, a global leader in genomics and precision medicine, announced today a partnership for the commercialization of ColoAlert in Italy and the United Arab Emirates (UAE). ColoAlert is Mainz’s flagship product, a highly efficacious and easy to use at-home detection test for colorectal cancer (CRC). Dante Labs is a global leader in genome sequencing with a product development and commercial franchise focused on providing personalized preventive healthcare solutions by leveraging its robust databases and proprietary software platform to offer next-generation diagnostic tools direct to co